Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?

Affiliations

Diane V Havlir. Proc Natl Acad Sci U S A. 2002.

. 2002 Jan 8;99(1):4-6.

doi: 10.1073/pnas.022629399.

¹ Division of Infectious Diseases, University of California, 150 West Washington Street, Suite 100, San Diego, CA 92103, USA. dhavlir@ucsd.edu

No abstract available

Comment on

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.
Dybul M, Chun TW, Yoder C, Hidalgo B, Belson M, Hertogs K, Larder B, Dewar RL, Fox CH, Hallahan CW, Justement JS, Migueles SA, Metcalf JA, Davey RT, Daucher M, Pandya P, Baseler M, Ward DJ, Fauci AS. Dybul M, et al. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15161-6. doi: 10.1073/pnas.261568398. Epub 2001 Dec 4. Proc Natl Acad Sci U S A. 2001. PMID: 11734634 Free PMC article.

1. Palella F J J, Delaney K M, Moorman A C, Loveless M O, Fuhrer J, Satten G A, Aschman D J, Holmberg S D. N Engl J Med. 1998;338:853–860. - PubMed
1. Ho D D, Neumann A U, Perelson A S, Chen W, Leonard J M, Markowitz M. Nature (London) 1995;373:123–126. - PubMed
1. Wei X, Ghosh S K, Taylor M E, Johnson V A, Emini E A, Deutsch P, Lifson J D, Bonhoeffer S, Nowak M A, Hahn B H. Nature (London) 1995;373:117–122. - PubMed
1. Coffin J M. Science. 1995;267:483–489. - PubMed
1. Mellors J W, Rinaldo C R, Jr, Gupta P, White R M, Todd J A, Kingsley L A. Science. 1996;272:1167–1170. - PubMed